Kenneth Y. Tsai
- Oncology top 1%
- Cutaneous Melanoma Detection and Management 12
- Polyomavirus and related diseases 12
- Cancer-related Molecular Pathways 11
- Biotechnology top 1%
- Molecular Biology top 2%
- Melanoma and MAPK Pathways 19
- Epigenetics and DNA Methylation 8
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Dermatology top 2%
-
- Nonmelanoma Skin Cancer Studies 12
-
- Immunotherapy and Immune Responses 9
Kenneth Y. Tsai
103 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 2.3k
- Biotechnology 475
- Molecular Biology 2.6k
- Cancer Research 564
- Dermatology 249
Countries citing papers authored by Kenneth Y. Tsai
This map shows the geographic impact of Kenneth Y. Tsai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Y. Tsai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Y. Tsai more than expected).
Fields of papers citing papers by Kenneth Y. Tsai
This network shows the impact of papers produced by Kenneth Y. Tsai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Y. Tsai. The network helps show where Kenneth Y. Tsai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenneth Y. Tsai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 19 | |
| 10 | 2021 | 27 | |
| 11 | 2020 | 6 | |
| 12 | 2019 | 20 | |
| 13 | 2019 | 111 | |
| 14 | 2019 | 6 | |
| 15 | 2017 | 23 | |
| 16 | 2015 | 67 | |
| 17 | 2014 | 116 | |
| 18 | 2013 | 25 | |
| 19 | 2009 | 1 | |
| 20 | 2002 | 35 |
About Kenneth Y. Tsai
Kenneth Y. Tsai is a scholar working on Oncology, Dermatology and Cancer Research, having authored 112 papers that have together received 4.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (19 papers), Cutaneous Melanoma Detection and Management (12 papers), Polyomavirus and related diseases (12 papers), Nonmelanoma Skin Cancer Studies (12 papers), Cancer-related Molecular Pathways (11 papers), Immunotherapy and Immune Responses (9 papers), Cancer Genomics and Diagnostics (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Oncology (2.3k citations), Biotechnology (475 citations) and Molecular Biology (2.6k citations). Kenneth Y. Tsai has collaborated with scholars based in United States, Egypt and United Kingdom. Frequent co-authors include Tyler Jacks, Elsa R. Flores, Denise Crowley, Annie Yang, Scott D. Boyd, Frank McKeon, Shomit Sengupta, Jeremy C. Smith, Andrew C. Phillips and William G. Kaelin. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.